PodcastAmplify Search the directory
RB
Artwork for Raising Biotech
Tech · General

Raising Biotech

Hosted by Surani Fernando.

Show website ↗ Listen on Apple ↗

Should you pitch it?

Guest activity
Often has guests
80% of recent episode titles look like interviews
Episode length
33 min
Median of recent episodes. That is the commitment you would be asking for.
Publishing
Occasional
28 episodes · last 2026-09-03
Language
English
The feed says "en" without a region, so the country is unknown.
Where it's from
Not established
No .uk domain and no region in the feed language. Apple reports the storefront, not the show, so we do not guess.
Reach
52
Percentile among shows you could realistically get on. Not a download count.
Check whether they charge. Some shows sell guest slots rather than booking them, and rates in some fields run to thousands. Nothing in a podcast feed reliably says so, so we do not claim either way. Ask before you write the pitch.
Worth a pitch. This show publishes its own contact, sits outside the national chart, is independently published, and its recent episodes show it books guests.

What the show says about itself

A narrative podcast series hosted by journalist Surani Fernando that goes beyond the headlines to explore how biotech companies are really built — from bold ideas and impressive fundraises to the science that could reshape healthcare. Surani speaks with founders, CEOs, investors, and experts to uncover origin stories, company missions, and the challenges of bringing ambitious discoveries to market. Through thoughtful, independent reporting, Raising Biotech examines what it really takes to turn breakthroughs into lasting impact for patients and the industry. For guest or sponsor pitches, please

Recent episodes

Straight from the feed. The quickest way to judge whether your angle fits.

  1. S4, E8: Infinimmune – From a Scientific Hunch to an $838M Merck Partnership, with CEO and co-founder Wyatt McDonell
  2. S4, E7: From the Archive – Revisiting Synchron and Brain-Computer Interfaces, 2 Years Later
  3. S4, E6: Investor Spotlight: From Cancer Physician to Biotech Investor, with Dr Jakob Dupont of Sofinnova Investments
  4. S4, E5: Compass Pathways and the Quest to Bring Psychedelics to Psychiatry, with CEO Kabir Nath and Prof David Nutt
  5. S4, E4: The Weight of the Moment: How GLP-1s are Rewiring Biotech Investing, Expert Analysis
  6. S4, E3: Inside Opus Genetics’ Pivot – Skepticism, Proxy Fights and a Comeback, with CEO George Magrath

This show publishes a contact

We hold the address this show publishes in its own feed. Addresses and drafted pitches are part of a plan. Browsing stays free, and we never send on your behalf.

Tell me when pitching opens